{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:37:35Z","timestamp":1775281055118,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI142762"],"award-info":[{"award-number":["1U19AI142762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI142762"],"award-info":[{"award-number":["1U19AI142762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI142762"],"award-info":[{"award-number":["1U19AI142762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103436"],"award-info":[{"award-number":["P20GM103436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103436"],"award-info":[{"award-number":["P20GM103436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30ES030283"],"award-info":[{"award-number":["P30ES030283"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Predictive Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76788-x","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:46:03Z","timestamp":1729831563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic and phenotypic changes to Venezuelan equine encephalitis virus following treatment with \u03b2-D-N4-hydroxycytidine, an RNA mutagen"],"prefix":"10.1038","volume":"14","author":[{"given":"Brian","family":"Alejandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juw Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghoon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"76788_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2217\/17460794.3.6.553","volume":"3","author":"JD Graci","year":"2008","unstructured":"Graci, J. D. & Cameron, C. E. Therapeutically targeting RNA viruses via lethal mutagenesis. Future Virol. 3, 553\u2013566 (2008).","journal-title":"Future Virol."},{"key":"76788_CR2","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4155\/fmc-2018-0457","volume":"11","author":"C Perales","year":"2019","unstructured":"Perales, C. et al. The increasing impact of lethal mutagenesis of viruses. Future Med. Chem. 11, 1645\u20131657 (2019).","journal-title":"Future Med. Chem."},{"key":"76788_CR3","doi-asserted-by":"crossref","unstructured":"Perales, C. & Domingo, E. Antiviral strategies based on lethal mutagenesis and error threshold. In Quasispecies: from Theory to Experimental Systems\u00a0vol. 392\u00a0 (eds Domingo, E. & Schuster, P.) 323\u2013339 (Springer International Publishing, Cham, 2015).","DOI":"10.1007\/82_2015_459"},{"key":"76788_CR4","doi-asserted-by":"crossref","unstructured":"Crotty, S., Cameron, C. E. & Andino, R. RNA virus error catastrophe: Direct molecular test by using ribavirin. Proc. Natl. Acad. Sci.\u00a098, 6895\u20136900 (2001).","DOI":"10.1073\/pnas.111085598"},{"key":"76788_CR5","doi-asserted-by":"publisher","first-page":"11722","DOI":"10.1128\/JVI.00874-07","volume":"81","author":"DH Chung","year":"2007","unstructured":"Chung, D. H. et al. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus. J. Virol. 81, 11722\u201311729 (2007).","journal-title":"J. Virol."},{"key":"76788_CR6","doi-asserted-by":"publisher","unstructured":"Chung, D. H. et al. The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without Ribavirin treatment. J. Virol. 10997\u201311007. https:\/\/doi.org\/10.1128\/JVI.01394-13 (2013).","DOI":"10.1128\/JVI.01394-13"},{"key":"76788_CR7","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1086\/315847","volume":"182","author":"I Jordan","year":"2000","unstructured":"Jordan, I., Briese, T., Fischer, N., Lau, J. Y. N. & Lipkin, W. I. Ribavirin inhibits west nile virus replication and cytopathic effect in neural cells. J. Infect. Dis. 182, 1214\u20131217 (2000).","journal-title":"J. Infect. Dis."},{"key":"76788_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Y Furuta","year":"2017","unstructured":"Furuta, Y., Komeno, T. & Nakamura, T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 93, 449\u2013463 (2017).","journal-title":"Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci."},{"key":"76788_CR9","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/JVI.02346-12","volume":"87","author":"T Baranovich","year":"2013","unstructured":"Baranovich, T. et al. T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J. Virol. 87, 3741\u20133751 (2013).","journal-title":"J. Virol."},{"key":"76788_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2005.04.002","volume":"67","author":"CW Day","year":"2005","unstructured":"Day, C. W. et al. Error-prone replication of West Nile virus caused by Ribavirin. Antiviral Res. 67, 38\u201345 (2005).","journal-title":"Antiviral Res."},{"key":"76788_CR11","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1073\/pnas.96.4.1492","volume":"96","author":"LA Loeb","year":"1999","unstructured":"Loeb, L. A. et al. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc. Natl. Acad. Sci. U S A. 96, 1492\u20131497 (1999).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"76788_CR12","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.1128\/JVI.77.12.7131-7138.2003","volume":"77","author":"N Pariente","year":"2003","unstructured":"Pariente, N., Airaksinen, A. & Domingo, E. Mutagenesis versus inhibition in the efficiency of extinction of Foot-and-Mouth Disease Virus. J. Virol. 77, 7131\u20137138 (2003).","journal-title":"J. Virol."},{"key":"76788_CR13","doi-asserted-by":"crossref","unstructured":"Ruiz-Jarabo, C. M., Ly, C., Domingo, E. & de Torre, J. C. la. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308, 37\u201347 (2003).","DOI":"10.1016\/S0042-6822(02)00046-6"},{"key":"76788_CR14","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1128\/AAC.01496-07","volume":"52","author":"JA Heck","year":"2008","unstructured":"Heck, J. A., Lam, A. M. I., Narayanan, N. & Frick, D. N. Effects of mutagenic and chain-terminating nucleotide analogs on enzymes isolated from hepatitis C virus strains of various genotypes. Antimicrob. Agents Chemother. 52, 1901\u20131911 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76788_CR15","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.1128\/JVI.76.17.8505-8517.2002","volume":"76","author":"AM Contreras","year":"2002","unstructured":"Contreras, A. M. et al. Viral RNA mutations are region specific and increased by Ribavirin in a full-length hepatitis C virus replication system. J. Virol. 76, 8505\u20138517 (2002).","journal-title":"J. Virol."},{"key":"76788_CR16","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/jac\/dku209","volume":"69","author":"L Delang","year":"2014","unstructured":"Delang, L. et al. Mutations in the Chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. J. Antimicrob. Chemother. 69, 2770\u20132784 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"76788_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.antiviral.2009.02.201","volume":"82","author":"JG Julander","year":"2009","unstructured":"Julander, J. G., Smee, D. F., Morrey, J. D. & Furuta, Y. Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Res. 82, 169\u2013171 (2009).","journal-title":"Antiviral Res."},{"key":"76788_CR18","doi-asserted-by":"publisher","first-page":"104883","DOI":"10.1016\/j.antiviral.2020.104883","volume":"182","author":"N Rabah","year":"2020","unstructured":"Rabah, N. et al. Mutations on VEEV nsP1 relate RNA capping efficiency to Ribavirin susceptibility. Antiviral Res. 182, 104883 (2020).","journal-title":"Antiviral Res."},{"key":"76788_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","volume":"8","author":"S Beaucourt","year":"2014","unstructured":"Beaucourt, S. & Vignuzzi, M. Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of Ribavirin resistance. Curr. Opin. Virol. 8, 10\u201315 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"76788_CR20","doi-asserted-by":"publisher","first-page":"22124","DOI":"10.1074\/jbc.M400908200","volume":"279","author":"I Bougie","year":"2004","unstructured":"Bougie, I. & Bisaillon, M. The Broad Spectrum Antiviral Nucleoside Ribavirin as a substrate for a viral RNA capping enzyme. J. Biol. Chem. 279, 22124\u201322130 (2004).","journal-title":"J. Biol. Chem."},{"key":"76788_CR21","doi-asserted-by":"crossref","unstructured":"Urakova, N. et al. \u03b2-D- N4 -Hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome. J. Virol. 92, e01965\u2013e01917 (2017). \/jvi\/92\/3\/e01965-17.atom","DOI":"10.1128\/JVI.01965-17"},{"key":"76788_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41594-021-00657-8","volume":"28","author":"B Malone","year":"2021","unstructured":"Malone, B. & Campbell, E. A. Molnupiravir: coding for catastrophe. Nat. Struct. Mol. Biol. 28, 706\u2013708 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"76788_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","volume":"28","author":"F Kabinger","year":"2021","unstructured":"Kabinger, F. et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat. Struct. Mol. Biol. 28, 740\u2013746 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"76788_CR24","doi-asserted-by":"publisher","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","volume":"12","author":"TP Sheahan","year":"2020","unstructured":"Sheahan, T. P. et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl Med. 12, eabb5883 (2020).","journal-title":"Sci. Transl Med."},{"key":"76788_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jiab247","volume":"224","author":"S Zhou","year":"2021","unstructured":"Zhou, S. et al. \u03b2- d - N 4-hydroxycytidine inhibits SARS-CoV-2 through Lethal Mutagenesis but is also mutagenic to mammalian cells. J. Infect. Dis. 224, 415\u2013419 (2021).","journal-title":"J. Infect. Dis."},{"key":"76788_CR26","doi-asserted-by":"publisher","first-page":"e00766","DOI":"10.1128\/AAC.00766-18","volume":"62","author":"JJ Yoon","year":"2018","unstructured":"Yoon, J. J. et al. Orally efficacious broad-spectrum Ribonucleoside Analog inhibitor of Influenza and respiratory syncytial viruses. Antimicrob. Agents Chemother. 62, e00766\u2013e00718 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76788_CR27","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1128\/JVI.02990-13","volume":"88","author":"C Sun","year":"2014","unstructured":"Sun, C. et al. High-level expression of reporter proteins from Improved Alphavirus expression vectors to track replication and dissemination during Encephalitic and Arthritogenic Disease. J. Virol. 88, 2035\u20132046 (2014).","journal-title":"J. Virol."},{"key":"76788_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","volume":"44","author":"W Markland","year":"2000","unstructured":"Markland, W., McQuaid, T. J., Jain, J. & Kwong, A. D. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with Ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 44, 859\u2013866 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76788_CR29","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1128\/AAC.00282-16","volume":"60","author":"DH Chung","year":"2016","unstructured":"Chung, D. H. et al. Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 Interferon-Independent Antiviral State. Antimicrob. Agents Chemother. 60, 4552\u20134562 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76788_CR30","doi-asserted-by":"publisher","unstructured":"Skidmore, A. M., Adcock, R. S., Jonsson, C. B., Golden, J. E. & Chung, D.-H. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production. Antivir. Res. 104674.\u00a0https:\/\/doi.org\/10.1016\/j.antiviral.2019.104674 (2019).","DOI":"10.1016\/j.antiviral.2019.104674"},{"key":"76788_CR31","doi-asserted-by":"publisher","first-page":"e01348","DOI":"10.1128\/JVI.01348-19","volume":"93","author":"ML Agostini","year":"2019","unstructured":"Agostini, M. L. et al. Small-molecule antiviral \u03b2- d - N4 -Hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J. Virol. 93, e01348\u2013e01319 (2019).","journal-title":"J. Virol."},{"key":"76788_CR32","doi-asserted-by":"publisher","unstructured":"FischerII, W. A. et al. A phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abl7430 (2021).","DOI":"10.1126\/scitranslmed.abl7430"},{"key":"76788_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1128\/AAC.47.1.244-254.2003","volume":"47","author":"LJ Stuyver","year":"2003","unstructured":"Stuyver, L. J. et al. Ribonucleoside Analogue that blocks replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture. Antimicrob. Agents Chemother. 47, 244\u2013254 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76788_CR34","doi-asserted-by":"publisher","first-page":"16038","DOI":"10.1073\/pnas.1111650108","volume":"108","author":"LL Coffey","year":"2011","unstructured":"Coffey, L. L., Beeharry, Y., Border\u00eda, A. V., Blanc, H. & Vignuzzi, M. Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc. Natl. Acad. Sci. U S A. 108, 16038\u201316043 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"76788_CR35","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1093\/hmg\/ddy177","volume":"27","author":"MO Pollard","year":"2018","unstructured":"Pollard, M. O., Gurdasani, D., Mentzer, A. J., Porter, T. & Sandhu, M. S. Long reads: their purpose and place. Hum. Mol. Genet. 27, R234\u2013R241 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"76788_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrg.2018.5","volume":"19","author":"DJ Burgess","year":"2018","unstructured":"Burgess, D. J. Next regeneration sequencing for reference genomes. Nat. Rev. Genet. 19, 125\u2013125 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"76788_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13059-020-1935-5","volume":"21","author":"SL Amarasinghe","year":"2020","unstructured":"Amarasinghe, S. L. et al. Opportunities and challenges in long-read sequencing data analysis. Genome Biol. 21, 30 (2020).","journal-title":"Genome Biol."},{"key":"76788_CR38","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1098\/rstb.2010.0063","volume":"365","author":"R Sanju\u00e1n","year":"2010","unstructured":"Sanju\u00e1n, R. Mutational fitness effects in RNA and single-stranded DNA viruses: common patterns revealed by site-directed mutagenesis studies. Phil Trans. R Soc. B. 365, 1975\u20131982 (2010).","journal-title":"Phil Trans. R Soc. B"},{"key":"76788_CR39","doi-asserted-by":"publisher","first-page":"e1000742","DOI":"10.1371\/journal.pgen.1000742","volume":"5","author":"P Domingo-Calap","year":"2009","unstructured":"Domingo-Calap, P., Cuevas, J. M. & Sanju\u00e1n, R. The Fitness effects of Random mutations in single-stranded DNA and RNA bacteriophages. PLoS Genet. 5, e1000742 (2009).","journal-title":"PLoS Genet."},{"key":"76788_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neo.2015.11.007","volume":"17","author":"P Danhier","year":"2015","unstructured":"Danhier, P. et al. Combining Optical Reporter proteins with different half-lives to detect temporal evolution of Hypoxia and Reoxygenation in Tumors. Neoplasia. 17, 871\u2013881 (2015).","journal-title":"Neoplasia"},{"key":"76788_CR41","doi-asserted-by":"publisher","unstructured":"Ojha, D. et al. N4 -Hydroxycytidine\/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness. Preprint at (2023). https:\/\/doi.org\/10.1101\/2023.08.22.554316","DOI":"10.1101\/2023.08.22.554316"},{"key":"76788_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/viro.2000.0546","volume":"276","author":"KA Bernard","year":"2000","unstructured":"Bernard, K. A., Klimstra, W. B. & Johnston, R. E. Mutations in the E2 glycoprotein of Venezuelan equine Encephalitis Virus Confer Heparan Sulfate Interaction, Low Morbidity, and Rapid Clearance from blood of mice. Virology 276, 93\u2013103 (2000).","journal-title":"Virology"},{"key":"76788_CR43","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"76788_CR44","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence Alignment\/Map format and SAMtools. Bioinformatics. 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"76788_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false Discovery rate: a practical and powerful Approach to multiple testing. J. Royal Stat. Soc. Ser. B (Methodological). 57, 289\u2013300 (1995).","journal-title":"J. Royal Stat. Soc. Ser. B (Methodological)"},{"key":"76788_CR46","doi-asserted-by":"crossref","unstructured":"Midani, F. S., Collins, J. & Britton, R. A. AMiGA: Software for automated analysis of microbial growth assays. mSystems 6, e00508-21 (2021).","DOI":"10.1128\/msystems.00508-21"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76788-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76788-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76788-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:46:34Z","timestamp":1729831594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76788-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76788"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76788-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25265"}}